NCT07133880View on ClinicalTrials.gov

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

PHASE4RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Interventions
DRUG

umeclidinium 62.5 µg and vilanterol 25 µg

DPI Treatment

DRUG

Revefenacin 175 µg, Formoterol 20 µg

Nebulizer Treatment

DRUG

Placebo ( Revefenacin and Formoterol )

Placebo Nebulizer Treatment

DRUG

Placebo DPI

Placebo DPI Treatment

Trial Locations (1)

37920

RECRUITING

The University of Tennessee Graduate School of Medicine, Knoxville

Sponsors

Collaborators (1)

Theravance Biopharma
All Listed Sponsors
collaborator

Theravance Biopharma

INDUSTRY

lead

University of Tennessee Graduate School of Medicine

OTHER